More NewsRead More
Repros Receives Confirmation of Eligibility for Submission of a Centralized Marketing Authorization Application to the European Medicines Agency as a New Active Substance
April 06, 2015
Repros Therapeutics Inc.(R) Reports Fourth Quarter and Year End 2014 Financial Results
March 16, 2015
Repros Submits New Drug Application to FDA for Androxal (R)
February 02, 2015
from Dividend Channel
Stock Market XML and JSON Data API provided by FinancialContent Services, Inc.
Nasdaq quotes delayed at least 15 minutes, all others at least 20 minutes.
Markets are closed on certain holidays. Stock Market Holiday List
By accessing this page, you agree to the following
Press Release Service provided by PRConnect.
Stock quotes supplied by Six Financial
Postage Rates Bots go here